A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Review uri icon

Overview

abstract

  • BACKGROUND: Sentinel lymph node biopsy (SLNB) is an established means of staging the axilla in patients with breast cancer. Recently, methylene blue dye has been shown to be an efficacious and cost-effective alternative to isosulfan blue. With the increasing popularity of SLNB, the potential complications of isosulfan blue use must be appreciated. METHODS: A literature search for English language articles available on MEDLINE from 1985 to November 2002 using the search terms allergy, allergic reaction, anaphylactic reactions, anaphylaxis, blue dye, breast cancer, isosulfan blue, methylene blue, and sentinel lymph node biopsy identified 24 reports. CONCLUSIONS: The use of isosulfan blue due for SLNB is associated with a significant number of allergic reactions, some of which are life-threatening. Because methylene blue dye has been shown to be equally effective and does not pose a serious risk of serious allergic reactions, it offers an improved technique above isosulfan blue dye for SLNB.

publication date

  • February 1, 2005

Research

keywords

  • Breast Neoplasms
  • Drug Hypersensitivity
  • Enzyme Inhibitors
  • Lymphatic Metastasis
  • Methylene Blue
  • Rosaniline Dyes
  • Sentinel Lymph Node Biopsy

Identity

Scopus Document Identifier

  • 13844275862

Digital Object Identifier (DOI)

  • 10.1016/j.amjsurg.2004.06.042

PubMed ID

  • 15720998

Additional Document Info

volume

  • 189

issue

  • 2